Osthole Improves Ovarian Function in Rats with Polycystic Ovary by Up-regulating PPARγ Expression

Li-na JIA,Xue-zhi KANG,Ya-ming LI,Xu ZHANG
DOI: https://doi.org/10.16306/j.1008-861x.2017.02.017
2017-01-01
Abstract:Objective:To observe the effects of osthole (OST) on ovarian function disorder and the protein expression of peroxisome proliferator-activated receptor-γ (PPARγ) in rats with polycystic ovary.Methods:36 SD rats were randomly divided into the model group,OST group and control group.Female SD rats in the model and OST group were received the light treatment for continuous 16 weeks to induce the status of polycystic ovary (PCO).From 14th week,OST was intraperitoneally injected in the OST group for 3 consecutive weeks.At the end of 16th week,the daily vaginal smears were compared and the pathological changes of ovarian were observed.The weight of ovary and uterus were measured,the serum levels of estradiol (E2) and testosterone (T) and the protein expression of PPARγwere determined.Results:In the model group,the ovarian cycle of rats disappeared and the polycystic ovary enlarged,the T level was increased and the protein expression of PPARγ in ovary was decreased.After the treatment with OST,the estrous cycle was increased,the serum level of E2 was increased,the ovarian enlargement was inhibited,and the expression level of PPARγ was increased,but there was no significant effect on the serum level of T.Conclusion:OST may play a role in improving the ovarian cycle disorder by up-regulating the protein expression of ovarian PPARγγ and can be taken as the choice for standardized treatment of polycystic ovary syndrome (PCOS).
What problem does this paper attempt to address?